🇺🇸 FDA

Company profile · Sponsor

Mundipharma

E39A946 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Mundipharma (E39A946) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E39A946
Exchange EMA
Company type pharma
Headquarters EU

Frequently asked questions

What is Mundipharma?

Mundipharma (E39A946) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Mundipharma sponsor?

We track 2 ClinicalTrials.gov-linked programs for Mundipharma, including Diflucan 200mg Hard Capsules, PLACEBO to Posaconazol hexal, Posaconazol HEXAL 100 mg, NOXAFIL® (posaconazole) Injection, Placebo to bactrim, diflucan 200 mg - microcrystalline cellulose capsules, DIFLUCAN INJECTION, REZZAYO 200 mg powder for concentrate for solution for infusion, Saline solution, REZZAYO 200 mg powder for concentrate for solution for infusion, Bactrim Tablets, NOXAFIL® (posaconazole) Delayed-Release Tablets and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Mundipharma company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.